| Year |
Citation |
Score |
| 2020 |
Gomes ED, Ghosh B, Lima R, Goulão M, Moreira-Gomes T, Martins-Macedo J, Urban MW, Wright MC, Gimble JM, Sousa N, Silva NA, Lepore AC, Salgado AJ. Combination of a Gellan Gum-Based Hydrogel With Cell Therapy for the Treatment of Cervical Spinal Cord Injury. Frontiers in Bioengineering and Biotechnology. 8: 984. PMID 32984278 DOI: 10.3389/fbioe.2020.00984 |
0.8 |
|
| 2020 |
Monteiro S, Pinho AG, Macieira M, Serre-Miranda C, Cibrão JR, Lima R, Soares-Cunha C, Vasconcelos NL, Lentilhas-Graça J, Duarte-Silva S, Miranda A, Correia-Neves M, Salgado AJ, Silva NA. Splenic sympathetic signaling contributes to acute neutrophil infiltration of the injured spinal cord. Journal of Neuroinflammation. 17: 282. PMID 32967684 DOI: 10.1186/s12974-020-01945-8 |
0.8 |
|
| 2020 |
Lima R, Monteiro S, Gomes ED, Vasconcelos NL, Assunção-Silva R, Morais M, Salgado AJ, Silva NA. Citalopram Administration Does Not Promote Function or Histological Recovery after Spinal Cord Injury. International Journal of Molecular Sciences. 21. PMID 32709070 DOI: 10.3390/ijms21145062 |
0.8 |
|
| 2020 |
Azevedo O, Marques N, Reis L, Cruz I, Craveiro N, Antunes H, Lourenço C, Gomes R, Guerreiro RA, Faria R, Sá F, Lima R, Gaspar P, Faria R, Miltenberger-Miltenyi G, et al. Predictors of Fabry disease in patients with hypertrophic cardiomyopathy: How to guide the diagnostic strategy? American Heart Journal. 226: 114-126. PMID 32531501 DOI: 10.1016/j.ahj.2020.04.006 |
0.8 |
|
| 2019 |
Costa MM, Lima R, Melo-Fonseca F, Bartolomeu F, Alves N, Miranda A, Gasik M, Silva FS, Silva NA, Miranda G. Development of β-TCP-Ti6Al4V structures: Driving cellular response by modulating physical and chemical properties. Materials Science & Engineering. C, Materials For Biological Applications. 98: 705-716. PMID 30813075 DOI: 10.1016/j.msec.2019.01.016 |
0.8 |
|
| 2017 |
Lima R, Monteiro S, Lopes JP, Barradas P, Vasconcelos NL, Gomes ED, Assunção-Silva RC, Teixeira FG, Morais M, Sousa N, Salgado AJ, Silva NA. Systemic Interleukin-4 Administration after Spinal Cord Injury Modulates Inflammation and Promotes Neuroprotection. Pharmaceuticals (Basel, Switzerland). 10. PMID 29064422 DOI: 10.3390/ph10040083 |
0.8 |
|
| 2016 |
Teixeira FG, Vasconcelos NL, Gomes ED, Marques F, Sousa JC, Sousa N, Silva NA, Assunção-Silva R, Lima R, Salgado AJ. Bioengineered cell culture systems of central nervous system injury and disease. Drug Discovery Today. PMID 27132519 DOI: 10.1016/j.drudis.2016.04.020 |
0.8 |
|
| 2016 |
Vasconcelos NL, Gomes ED, Oliveira EP, Silva CJ, Lima R, Sousa N, Salgado AJ, Silva NA. Combing neuroprotective agents: effect of riluzole and magnesium in a rat model of thoracic spinal cord injury. The Spine Journal : Official Journal of the North American Spine Society. PMID 27109831 DOI: 10.1016/j.spinee.2016.04.013 |
0.8 |
|
| 2015 |
da Mota LM, Cruz BA, Albuquerque CP, Gonçalves D, Laurindo IM, Pereira IA, Carvalho JF, Pinheiro Gda R, Bertolo MB, Silva NA, Louzada Júnior P, Xavier RM, Giorgi RD, Lima RA. [Preliminary guidelines of the Brazilian Society of Rheumatology for evaluation and treatment of tuberculosis latent infection in patients with rheumatoid arthritis, in face of unavailability of the tuberculin skin test]. Revista Brasileira De Reumatologia. 55: 390-3. PMID 26165801 DOI: 10.1016/j.rbr.2015.01.006 |
0.8 |
|
| 2013 |
Carvalho MM, Campos FL, Coimbra B, Pêgo JM, Rodrigues C, Lima R, Rodrigues AJ, Sousa N, Salgado AJ. Behavioral characterization of the 6-hydroxidopamine model of Parkinson's disease and pharmacological rescuing of non-motor deficits. Molecular Neurodegeneration. 8: 14. PMID 23621954 DOI: 10.1186/1750-1326-8-14 |
0.36 |
|
| Show low-probability matches. |